Health system intelligence profile
Corewell Health
Last reviewed August 30, 2026
Intelligence summary
Documented successes: Publishes a transparent 50/50 net-proceeds split between Corewell Health and inventors after cost recovery, with no revenue caps reducing inventor compensation (Innovations Office page); Offers both organization-led and inventor-led commercialization pathways with a streamlined invention disclosure form; Provides IP evaluation and protection, prototype development, funding acquisition support, global market assessment and industry matchmaking to Corewell Health staff
Mandate and remit
The Innovations Office is Corewell Health's commercialization arm, housed within the Corewell Health Research Institute in Southeast Michigan, that turns employee and researcher ideas into products, services or licenses. It evaluates submitted ideas for market potential and intellectual property protection, supports prototype development and funding acquisition, performs global market assessment, and connects innovations to industry partners. Inventors submit through an invention disclosure form, and the office offers both organization-led and inventor-led development pathways depending on who drives the project. Its revenue-sharing terms are published: a 50/50 split of net proceeds between Corewell Health and the inventors after cost recovery, with no revenue caps that would reduce inventor compensation. Outside companies engage the office as licensees and development or distribution partners for Corewell Health technologies. It is distinct from Corewell Health Ventures, the system's investment arm.
These routes appear in the program's sourced public record.
Documented successes
Publishes a transparent 50/50 net-proceeds split between Corewell Health and inventors after cost recovery, with no revenue caps reducing inventor compensation (Innovations Office page); Offers both organization-led and inventor-led commercialization pathways with a streamlined invention disclosure form; Provides IP evaluation and protection, prototype development, funding acquisition support, global market assessment and industry matchmaking to Corewell Health staff
Use the program's published contact route for partnership, licensing, innovation, or program inquiries.
Comparable records based on shared public taxonomy, location, or commercialization route.
Same state · Same program type · Same commercialization route
Detroit, Michigan
Henry Ford + MSU Innovation Fund (Henry Ford Innovations)
Henry Ford Health and Michigan State University launched a joint Innovation Hub in 2025 anchored by a $10 million venture fund, the Henry Ford + MSU Innovation Fund, managed with the MSU Research Foundation.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Fast Forward Medical Innovation
Michigan Medicine's Fast Forward Medical Innovation (FFMI) is an official biomedical commercialization and entrepreneurship program that describes itself as a front door to biomedical commercialization at the University of Michigan.
Academic
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Coulter Translational Research Partnership Program
The U-M Coulter Translational Research Partnership funds collaborative projects that pair a biomedical engineering faculty member with a Michigan Medicine clinical faculty member to accelerate development and commercialization of medical devices, diagnostics and other biomedical products addressing unmet clinical needs.
Academic · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
U-M Innovation Partnerships
Innovation Partnerships is the University of Michigan's central technology transfer and commercialization unit, handling invention disclosures, patents and licenses for the entire university including Michigan Medicine's clinical and biomedical research.
Academic · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Michigan Biomedical Venture Fund
The Michigan Biomedical Venture Fund is an early-stage investment program within Fast Forward Medical Innovation at the University of Michigan Medical School.
Academic · Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same program type · Same commercialization route
Charlotte, North Carolina
Advocate Health Innovation (Innovative Collaborations and Technology Transfer Office)
Advocate Health's enterprise innovation function is led by a Chief Innovation and Commercialization Officer and combines an external-partnership front door with an internal commercialization office.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Reviewed August 30, 2026. External source links open in a new tab.
Confidential comparison
Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.